Search alternatives:
significant interventions » significant interactions (Expand Search), significant interaction (Expand Search), significant alterations (Expand Search)
interventions included » intervention included (Expand Search), interventions tailored (Expand Search)
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
Showing 1 - 20 results of 30,114 for search '(( significant ((fold decrease) OR (point decrease)) ) OR ( significant interventions included ))', query time: 1.69s Refine Results
  1. 1
    Main characteristics of included papers.

    Main characteristics of included papers. by Giacomo Stroffolini (11716410)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  2. 2
    Deletion of <i>sagA</i> alone results in a decrease in nasopharyngeal infection.

    Deletion of <i>sagA</i> alone results in a decrease in nasopharyngeal infection. by Blake A. Shannon (14197601)

    Published 2024
    Save to List
    Saved in:
  3. 3
    The list of included studies.

    The list of included studies. by Yu Zhou (89766)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  4. 4
    Pro- and anti-inflammatory cytokines are significantly decreased at acute time points following IR.

    Pro- and anti-inflammatory cytokines are significantly decreased at acute time points following IR. by Jordan A. Gunning (18143970)

    Published 2024
    Save to List
    Saved in:
  5. 5
    Number of significant genes and fold change.

    Number of significant genes and fold change. by Gordon A. Barr (11163243)

    Published 2023
    Save to List
    Saved in:
  6. 6
    Comparison of Week 0 and Week 16 outcomes in the intervention and control groups.

    Comparison of Week 0 and Week 16 outcomes in the intervention and control groups. by Shayan Shirazian (9922110)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  7. 7
    Gene expression of CD14+ leucocytes following elective percutaneous coronary intervention, showing the change in gene expression (fold change compared to baseline) of CD14+ leucocytes following elective angioplasty.

    Gene expression of CD14+ leucocytes following elective percutaneous coronary intervention, showing the change in gene expression (fold change compared to baseline) of CD14+ leucocy... by Ioannis Merinopoulos (11106088)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  8. 8
    Characteristics of the interventions in the included studies.

    Characteristics of the interventions in the included studies. by Fang Lei (42063)

    Published 2023
    Save to List
    Saved in:
  9. 9
    Intervention characteristics of the included studies.

    Intervention characteristics of the included studies. by Birgit A. Greiner (10050984)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  10. 10
    Characteristics of included interventions.

    Characteristics of included interventions. by Syreen Hassan (5429687)

    Published 2025
    “…Eighteen studies were included, covering interventions in 13 LMICs. We identified four levels of influencing the implementation of chronic condition management interventions: individual (service users and providers), community, health system/policy, and interpersonal. …”
    Save to List
    Saved in:
  11. 11
    Summary of post-treatment disease course measures from MDMA-AT publications.

    Summary of post-treatment disease course measures from MDMA-AT publications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 12
    Study selection criteria.

    Study selection criteria. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 13
    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.

    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 14
    Disease course measures after the PTSD treatments.

    Disease course measures after the PTSD treatments. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 15
    PICOS criteria for the SLR.

    PICOS criteria for the SLR. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 16
    Summary of post-treatment CAPS score changes from MDMA-AT publications.

    Summary of post-treatment CAPS score changes from MDMA-AT publications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 17
    Summary of post-treatment disease course measures from off-label medications clinical trials.

    Summary of post-treatment disease course measures from off-label medications clinical trials. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 18
    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.

    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 19
    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.

    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 20
    Summary of post-treatment disease course measures from clinical trials with psychotherapies.

    Summary of post-treatment disease course measures from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: